

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 4.86406440 |
| 2 | behavioral response to nicotine (GO:0035095) | 4.39961586 |
| 3 | protein complex biogenesis (GO:0070271) | 4.11576783 |
| 4 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.10946042 |
| 5 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.10946042 |
| 6 | NADH dehydrogenase complex assembly (GO:0010257) | 4.10946042 |
| 7 | ATP synthesis coupled proton transport (GO:0015986) | 4.01795116 |
| 8 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.01795116 |
| 9 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.79299004 |
| 10 | negative regulation of telomere maintenance (GO:0032205) | 3.75815532 |
| 11 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.70355801 |
| 12 | metallo-sulfur cluster assembly (GO:0031163) | 3.66545528 |
| 13 | iron-sulfur cluster assembly (GO:0016226) | 3.66545528 |
| 14 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.53447811 |
| 15 | base-excision repair, AP site formation (GO:0006285) | 3.50386149 |
| 16 | positive regulation of prostaglandin secretion (GO:0032308) | 3.27583967 |
| 17 | electron transport chain (GO:0022900) | 3.21183794 |
| 18 | negative regulation of mast cell activation (GO:0033004) | 3.20607194 |
| 19 | respiratory electron transport chain (GO:0022904) | 3.17905062 |
| 20 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.01410629 |
| 21 | chaperone-mediated protein transport (GO:0072321) | 2.98790701 |
| 22 | fucose catabolic process (GO:0019317) | 2.97174802 |
| 23 | L-fucose metabolic process (GO:0042354) | 2.97174802 |
| 24 | L-fucose catabolic process (GO:0042355) | 2.97174802 |
| 25 | cytochrome complex assembly (GO:0017004) | 2.96634772 |
| 26 | positive regulation of defense response to virus by host (GO:0002230) | 2.95892016 |
| 27 | positive regulation of fatty acid transport (GO:2000193) | 2.94019059 |
| 28 | negative regulation of appetite (GO:0032099) | 2.93369033 |
| 29 | negative regulation of response to food (GO:0032096) | 2.93369033 |
| 30 | response to interferon-beta (GO:0035456) | 2.87372625 |
| 31 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.86547933 |
| 32 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.85065596 |
| 33 | platelet dense granule organization (GO:0060155) | 2.81821392 |
| 34 | autophagic vacuole fusion (GO:0000046) | 2.81478923 |
| 35 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.81004234 |
| 36 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.81004234 |
| 37 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.79770292 |
| 38 | cellular response to interferon-beta (GO:0035458) | 2.77647251 |
| 39 | mannosylation (GO:0097502) | 2.77079185 |
| 40 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.77075786 |
| 41 | deoxyribonucleotide catabolic process (GO:0009264) | 2.73468673 |
| 42 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.73315502 |
| 43 | positive regulation of icosanoid secretion (GO:0032305) | 2.71959926 |
| 44 | respiratory chain complex IV assembly (GO:0008535) | 2.71645801 |
| 45 | ubiquinone biosynthetic process (GO:0006744) | 2.71636731 |
| 46 | protein-cofactor linkage (GO:0018065) | 2.71408559 |
| 47 | positive regulation of antigen processing and presentation (GO:0002579) | 2.69627407 |
| 48 | indole-containing compound catabolic process (GO:0042436) | 2.68782636 |
| 49 | indolalkylamine catabolic process (GO:0046218) | 2.68782636 |
| 50 | tryptophan catabolic process (GO:0006569) | 2.68782636 |
| 51 | hydrogen ion transmembrane transport (GO:1902600) | 2.66750396 |
| 52 | cytidine metabolic process (GO:0046087) | 2.65186518 |
| 53 | cytidine catabolic process (GO:0006216) | 2.65186518 |
| 54 | cytidine deamination (GO:0009972) | 2.65186518 |
| 55 | GTP biosynthetic process (GO:0006183) | 2.64813153 |
| 56 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.63615650 |
| 57 | kynurenine metabolic process (GO:0070189) | 2.63401988 |
| 58 | sulfation (GO:0051923) | 2.62883272 |
| 59 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.60458893 |
| 60 | ATP biosynthetic process (GO:0006754) | 2.59083864 |
| 61 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.56184330 |
| 62 | viral transcription (GO:0019083) | 2.52764990 |
| 63 | protein polyglutamylation (GO:0018095) | 2.51495416 |
| 64 | proton transport (GO:0015992) | 2.50803293 |
| 65 | NAD biosynthetic process (GO:0009435) | 2.49740685 |
| 66 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.47498586 |
| 67 | hydrogen transport (GO:0006818) | 2.46556445 |
| 68 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.43837845 |
| 69 | indolalkylamine metabolic process (GO:0006586) | 2.43534979 |
| 70 | positive regulation of organic acid transport (GO:0032892) | 2.42146214 |
| 71 | negative regulation of B cell apoptotic process (GO:0002903) | 2.40021383 |
| 72 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.39909494 |
| 73 | GPI anchor metabolic process (GO:0006505) | 2.38546531 |
| 74 | deoxyribose phosphate catabolic process (GO:0046386) | 2.38283567 |
| 75 | cellular response to exogenous dsRNA (GO:0071360) | 2.37721244 |
| 76 | synaptic transmission, cholinergic (GO:0007271) | 2.37250777 |
| 77 | detection of light stimulus involved in visual perception (GO:0050908) | 2.37000867 |
| 78 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.37000867 |
| 79 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.33813076 |
| 80 | cellular response to ATP (GO:0071318) | 2.32866330 |
| 81 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.31570813 |
| 82 | ubiquinone metabolic process (GO:0006743) | 2.29507427 |
| 83 | response to pheromone (GO:0019236) | 2.29461632 |
| 84 | protein neddylation (GO:0045116) | 2.28273827 |
| 85 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.28269845 |
| 86 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.28269845 |
| 87 | cellular biogenic amine catabolic process (GO:0042402) | 2.26719581 |
| 88 | amine catabolic process (GO:0009310) | 2.26719581 |
| 89 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.25015884 |
| 90 | translational termination (GO:0006415) | 2.24755586 |
| 91 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.24645820 |
| 92 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.24249145 |
| 93 | pseudouridine synthesis (GO:0001522) | 2.23700325 |
| 94 | regulation of defense response to virus by host (GO:0050691) | 2.21003545 |
| 95 | regulation of prostaglandin secretion (GO:0032306) | 2.20762958 |
| 96 | tRNA modification (GO:0006400) | 2.19806618 |
| 97 | regulation of antigen processing and presentation (GO:0002577) | 2.19729259 |
| 98 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.19029121 |
| 99 | organelle membrane fusion (GO:0090174) | 2.18848593 |
| 100 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.18474034 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.22796474 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.95920829 |
| 3 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.86806975 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.84135154 |
| 5 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.56138117 |
| 6 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.38953014 |
| 7 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.32301629 |
| 8 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.30082439 |
| 9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.29900243 |
| 10 | BCL6_27268052_Chip-Seq_Bcells_Human | 2.19075977 |
| 11 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.02720440 |
| 12 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 2.01552907 |
| 13 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.00864487 |
| 14 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98092708 |
| 15 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.92283222 |
| 16 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.86797384 |
| 17 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.82599327 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80818415 |
| 19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.80110556 |
| 20 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.80009514 |
| 21 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.75497686 |
| 22 | P68_20966046_ChIP-Seq_HELA_Human | 1.73402100 |
| 23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.72976916 |
| 24 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.71427941 |
| 25 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.71262185 |
| 26 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.68800446 |
| 27 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.66097025 |
| 28 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.63260127 |
| 29 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.62660321 |
| 30 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 1.62600741 |
| 31 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.62586195 |
| 32 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.58598976 |
| 33 | ERA_21632823_ChIP-Seq_H3396_Human | 1.58288092 |
| 34 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.57281910 |
| 35 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56150527 |
| 36 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.55391519 |
| 37 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.55245593 |
| 38 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.46076934 |
| 39 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.45072160 |
| 40 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.44691704 |
| 41 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.44442982 |
| 42 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.44052015 |
| 43 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.42054839 |
| 44 | SA1_27219007_Chip-Seq_Bcells_Human | 1.41868972 |
| 45 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.41464774 |
| 46 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.39394149 |
| 47 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.30529815 |
| 48 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30453762 |
| 49 | P300_27268052_Chip-Seq_Bcells_Human | 1.29655398 |
| 50 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.28994151 |
| 51 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.27338973 |
| 52 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.27315231 |
| 53 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26478158 |
| 54 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.25557587 |
| 55 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.24021427 |
| 56 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.23990471 |
| 57 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.22986634 |
| 58 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.21599366 |
| 59 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21282851 |
| 60 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.20072514 |
| 61 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.19301876 |
| 62 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.18656037 |
| 63 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.18524124 |
| 64 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.18517581 |
| 65 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.18341695 |
| 66 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.16718347 |
| 67 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.15962626 |
| 68 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.15735734 |
| 69 | VDR_22108803_ChIP-Seq_LS180_Human | 1.15683310 |
| 70 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.15464264 |
| 71 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.15226018 |
| 72 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.14965127 |
| 73 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.14481401 |
| 74 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.13505615 |
| 75 | MAF_26560356_Chip-Seq_TH2_Human | 1.12345123 |
| 76 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.11260267 |
| 77 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10585004 |
| 78 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.10569258 |
| 79 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.10462527 |
| 80 | * TP53_22573176_ChIP-Seq_HFKS_Human | 1.10461350 |
| 81 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.10400814 |
| 82 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10094440 |
| 83 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08968091 |
| 84 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08704286 |
| 85 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.08647550 |
| 86 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.08335039 |
| 87 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.08096287 |
| 88 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.08022058 |
| 89 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.08002992 |
| 90 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.07224906 |
| 91 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.06212511 |
| 92 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.05288856 |
| 93 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.05023283 |
| 94 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.04269559 |
| 95 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.04196211 |
| 96 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.04163329 |
| 97 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.03141309 |
| 98 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.02911740 |
| 99 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02853320 |
| 100 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.01575610 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 2.60504290 |
| 2 | MP0003646_muscle_fatigue | 2.59231181 |
| 3 | MP0001968_abnormal_touch/_nociception | 2.26040842 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 2.10886608 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 2.07415835 |
| 6 | MP0002653_abnormal_ependyma_morphology | 2.07225016 |
| 7 | MP0002837_dystrophic_cardiac_calcinosis | 1.96078527 |
| 8 | MP0005645_abnormal_hypothalamus_physiol | 1.92486061 |
| 9 | MP0001835_abnormal_antigen_presentation | 1.86726461 |
| 10 | MP0000685_abnormal_immune_system | 1.83068377 |
| 11 | MP0003436_decreased_susceptibility_to | 1.76583024 |
| 12 | MP0008875_abnormal_xenobiotic_pharmacok | 1.74629198 |
| 13 | MP0005387_immune_system_phenotype | 1.74602694 |
| 14 | MP0001790_abnormal_immune_system | 1.74602694 |
| 15 | MP0002736_abnormal_nociception_after | 1.74410537 |
| 16 | MP0003724_increased_susceptibility_to | 1.72673746 |
| 17 | MP0001986_abnormal_taste_sensitivity | 1.69611860 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.66846205 |
| 19 | MP0005551_abnormal_eye_electrophysiolog | 1.64496397 |
| 20 | MP0001800_abnormal_humoral_immune | 1.61156091 |
| 21 | MP0009379_abnormal_foot_pigmentation | 1.60402731 |
| 22 | MP0003011_delayed_dark_adaptation | 1.58852793 |
| 23 | MP0008872_abnormal_physiological_respon | 1.58375531 |
| 24 | MP0009764_decreased_sensitivity_to | 1.54622173 |
| 25 | MP0004145_abnormal_muscle_electrophysio | 1.54299060 |
| 26 | MP0002723_abnormal_immune_serum | 1.53503821 |
| 27 | MP0006082_CNS_inflammation | 1.53397633 |
| 28 | MP0009745_abnormal_behavioral_response | 1.53197667 |
| 29 | MP0009785_altered_susceptibility_to | 1.52875394 |
| 30 | MP0005000_abnormal_immune_tolerance | 1.52814374 |
| 31 | MP0001905_abnormal_dopamine_level | 1.52370399 |
| 32 | MP0004142_abnormal_muscle_tone | 1.52022446 |
| 33 | MP0005025_abnormal_response_to | 1.51413088 |
| 34 | MP0005646_abnormal_pituitary_gland | 1.49644563 |
| 35 | MP0006292_abnormal_olfactory_placode | 1.48908095 |
| 36 | MP0001873_stomach_inflammation | 1.47704868 |
| 37 | MP0002452_abnormal_antigen_presenting | 1.39050526 |
| 38 | MP0002272_abnormal_nervous_system | 1.33968026 |
| 39 | MP0002420_abnormal_adaptive_immunity | 1.33592955 |
| 40 | MP0001819_abnormal_immune_cell | 1.32715350 |
| 41 | MP0006036_abnormal_mitochondrial_physio | 1.31308485 |
| 42 | MP0003880_abnormal_central_pattern | 1.29393947 |
| 43 | MP0002733_abnormal_thermal_nociception | 1.29038396 |
| 44 | MP0002064_seizures | 1.28276193 |
| 45 | MP0001970_abnormal_pain_threshold | 1.27654163 |
| 46 | MP0004742_abnormal_vestibular_system | 1.26452686 |
| 47 | MP0005084_abnormal_gallbladder_morpholo | 1.21269958 |
| 48 | MP0002419_abnormal_innate_immunity | 1.21047337 |
| 49 | MP0001501_abnormal_sleep_pattern | 1.20921171 |
| 50 | MP0002876_abnormal_thyroid_physiology | 1.19552197 |
| 51 | MP0000372_irregular_coat_pigmentation | 1.16165086 |
| 52 | MP0003195_calcinosis | 1.14949722 |
| 53 | MP0009046_muscle_twitch | 1.14724113 |
| 54 | MP0002277_abnormal_respiratory_mucosa | 1.12398898 |
| 55 | MP0002822_catalepsy | 1.12236267 |
| 56 | MP0001663_abnormal_digestive_system | 1.11126870 |
| 57 | MP0003878_abnormal_ear_physiology | 1.11029553 |
| 58 | MP0005377_hearing/vestibular/ear_phenot | 1.11029553 |
| 59 | MP0001486_abnormal_startle_reflex | 1.09898959 |
| 60 | MP0002735_abnormal_chemical_nociception | 1.06017171 |
| 61 | MP0006072_abnormal_retinal_apoptosis | 1.05808017 |
| 62 | MP0002572_abnormal_emotion/affect_behav | 1.05674294 |
| 63 | MP0004130_abnormal_muscle_cell | 1.05632161 |
| 64 | MP0009333_abnormal_splenocyte_physiolog | 1.05303138 |
| 65 | MP0001485_abnormal_pinna_reflex | 1.05034922 |
| 66 | MP0002638_abnormal_pupillary_reflex | 0.99249330 |
| 67 | MP0004147_increased_porphyrin_level | 0.98178125 |
| 68 | MP0000716_abnormal_immune_system | 0.97840268 |
| 69 | MP0003186_abnormal_redox_activity | 0.97719415 |
| 70 | MP0002102_abnormal_ear_morphology | 0.97356001 |
| 71 | MP0009840_abnormal_foam_cell | 0.96948777 |
| 72 | MP0002405_respiratory_system_inflammati | 0.96485839 |
| 73 | MP0004043_abnormal_pH_regulation | 0.95755467 |
| 74 | MP0001845_abnormal_inflammatory_respons | 0.95193105 |
| 75 | MP0006276_abnormal_autonomic_nervous | 0.95176182 |
| 76 | MP0003635_abnormal_synaptic_transmissio | 0.94223099 |
| 77 | MP0005423_abnormal_somatic_nervous | 0.93418938 |
| 78 | MP0008995_early_reproductive_senescence | 0.93012471 |
| 79 | MP0005058_abnormal_lysosome_morphology | 0.92761105 |
| 80 | MP0002254_reproductive_system_inflammat | 0.92237684 |
| 81 | MP0002163_abnormal_gland_morphology | 0.92227272 |
| 82 | MP0005075_abnormal_melanosome_morpholog | 0.91667593 |
| 83 | MP0008469_abnormal_protein_level | 0.90144406 |
| 84 | MP0005389_reproductive_system_phenotype | 0.89908412 |
| 85 | MP0004133_heterotaxia | 0.88968952 |
| 86 | MP0003137_abnormal_impulse_conducting | 0.88746630 |
| 87 | MP0001919_abnormal_reproductive_system | 0.88239130 |
| 88 | MP0005167_abnormal_blood-brain_barrier | 0.87615841 |
| 89 | MP0000604_amyloidosis | 0.87475564 |
| 90 | MP0001533_abnormal_skeleton_physiology | 0.87412125 |
| 91 | MP0009278_abnormal_bone_marrow | 0.86019656 |
| 92 | MP0000689_abnormal_spleen_morphology | 0.85170878 |
| 93 | MP0001963_abnormal_hearing_physiology | 0.84166620 |
| 94 | MP0001764_abnormal_homeostasis | 0.83205296 |
| 95 | MP0002557_abnormal_social/conspecific_i | 0.81958944 |
| 96 | MP0005253_abnormal_eye_physiology | 0.81790768 |
| 97 | MP0003763_abnormal_thymus_physiology | 0.81470428 |
| 98 | MP0002933_joint_inflammation | 0.81194408 |
| 99 | MP0001529_abnormal_vocalization | 0.80820382 |
| 100 | MP0003638_abnormal_response/metabolism_ | 0.79904761 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Mitochondrial inheritance (HP:0001427) | 3.81243987 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 3.64874792 |
| 3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.57467885 |
| 4 | Hepatocellular necrosis (HP:0001404) | 3.53886985 |
| 5 | Congenital stationary night blindness (HP:0007642) | 3.42501403 |
| 6 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.39673589 |
| 7 | Increased CSF lactate (HP:0002490) | 3.26640607 |
| 8 | 3-Methylglutaconic aciduria (HP:0003535) | 3.23545758 |
| 9 | Hepatic necrosis (HP:0002605) | 3.19590821 |
| 10 | Acute encephalopathy (HP:0006846) | 3.16153841 |
| 11 | Increased intramyocellular lipid droplets (HP:0012240) | 2.96587981 |
| 12 | Progressive macrocephaly (HP:0004481) | 2.96275536 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.95606389 |
| 14 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.94577761 |
| 15 | Abnormal number of erythroid precursors (HP:0012131) | 2.89180431 |
| 16 | Attenuation of retinal blood vessels (HP:0007843) | 2.84209107 |
| 17 | Renal Fanconi syndrome (HP:0001994) | 2.81633666 |
| 18 | Increased muscle lipid content (HP:0009058) | 2.81355818 |
| 19 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.76038984 |
| 20 | Stomatitis (HP:0010280) | 2.72117353 |
| 21 | Abolished electroretinogram (ERG) (HP:0000550) | 2.68803476 |
| 22 | Optic disc pallor (HP:0000543) | 2.68082731 |
| 23 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.64277501 |
| 24 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.64277501 |
| 25 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.64232396 |
| 26 | Pancreatic cysts (HP:0001737) | 2.60718107 |
| 27 | Pendular nystagmus (HP:0012043) | 2.58206928 |
| 28 | Abnormality of glycolipid metabolism (HP:0010969) | 2.52807541 |
| 29 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.52807541 |
| 30 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.52807541 |
| 31 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.51706152 |
| 32 | Molar tooth sign on MRI (HP:0002419) | 2.50438353 |
| 33 | Abnormality of midbrain morphology (HP:0002418) | 2.50438353 |
| 34 | Lactic acidosis (HP:0003128) | 2.49889985 |
| 35 | Lipid accumulation in hepatocytes (HP:0006561) | 2.44091625 |
| 36 | Progressive microcephaly (HP:0000253) | 2.42477685 |
| 37 | True hermaphroditism (HP:0010459) | 2.40199863 |
| 38 | Abnormality of alanine metabolism (HP:0010916) | 2.35185405 |
| 39 | Hyperalaninemia (HP:0003348) | 2.35185405 |
| 40 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.35185405 |
| 41 | Increased hepatocellular lipid droplets (HP:0006565) | 2.34351477 |
| 42 | Pancreatic fibrosis (HP:0100732) | 2.34345750 |
| 43 | Increased serum lactate (HP:0002151) | 2.33425024 |
| 44 | Type II lissencephaly (HP:0007260) | 2.33189442 |
| 45 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.26785477 |
| 46 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.19386544 |
| 47 | Nephronophthisis (HP:0000090) | 2.18374754 |
| 48 | Increased IgM level (HP:0003496) | 2.14935830 |
| 49 | IgG deficiency (HP:0004315) | 2.13530333 |
| 50 | Decreased central vision (HP:0007663) | 2.12917238 |
| 51 | Mesangial abnormality (HP:0001966) | 2.12471071 |
| 52 | Agitation (HP:0000713) | 2.11463443 |
| 53 | Methylmalonic aciduria (HP:0012120) | 2.09964725 |
| 54 | Generalized aminoaciduria (HP:0002909) | 2.08766530 |
| 55 | Panhypogammaglobulinemia (HP:0003139) | 2.06110681 |
| 56 | Polydipsia (HP:0001959) | 2.05366146 |
| 57 | Abnormal drinking behavior (HP:0030082) | 2.05366146 |
| 58 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.05170239 |
| 59 | Dicarboxylic aciduria (HP:0003215) | 2.05170239 |
| 60 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.02113982 |
| 61 | Cerebral edema (HP:0002181) | 2.02091587 |
| 62 | Respiratory failure (HP:0002878) | 2.00031746 |
| 63 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.98693954 |
| 64 | Increased cerebral lipofuscin (HP:0011813) | 1.98482787 |
| 65 | Concave nail (HP:0001598) | 1.95987001 |
| 66 | Cerebral palsy (HP:0100021) | 1.94513420 |
| 67 | Medial flaring of the eyebrow (HP:0010747) | 1.90088390 |
| 68 | Congenital, generalized hypertrichosis (HP:0004540) | 1.89126015 |
| 69 | Mediastinal lymphadenopathy (HP:0100721) | 1.87414569 |
| 70 | Severe muscular hypotonia (HP:0006829) | 1.86978526 |
| 71 | Recurrent fungal infections (HP:0002841) | 1.85966844 |
| 72 | Polyphagia (HP:0002591) | 1.82932435 |
| 73 | Lethargy (HP:0001254) | 1.81425730 |
| 74 | Autoimmune thrombocytopenia (HP:0001973) | 1.81349062 |
| 75 | Severe visual impairment (HP:0001141) | 1.79324878 |
| 76 | Vacuolated lymphocytes (HP:0001922) | 1.77823257 |
| 77 | Exertional dyspnea (HP:0002875) | 1.77293550 |
| 78 | Mutism (HP:0002300) | 1.77226220 |
| 79 | Opisthotonus (HP:0002179) | 1.77221514 |
| 80 | Polyuria (HP:0000103) | 1.75797221 |
| 81 | Exercise intolerance (HP:0003546) | 1.73000893 |
| 82 | Severe combined immunodeficiency (HP:0004430) | 1.72946089 |
| 83 | Myositis (HP:0100614) | 1.71775516 |
| 84 | Recurrent cutaneous fungal infections (HP:0011370) | 1.70993969 |
| 85 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.70993969 |
| 86 | Emotional lability (HP:0000712) | 1.69457952 |
| 87 | Prostate neoplasm (HP:0100787) | 1.68698325 |
| 88 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.68676086 |
| 89 | Myokymia (HP:0002411) | 1.67468529 |
| 90 | Abnormality of the renal medulla (HP:0100957) | 1.66961862 |
| 91 | Gliosis (HP:0002171) | 1.66257982 |
| 92 | Inability to walk (HP:0002540) | 1.66252990 |
| 93 | Glycosuria (HP:0003076) | 1.65355030 |
| 94 | Abnormality of urine glucose concentration (HP:0011016) | 1.65355030 |
| 95 | Cystic liver disease (HP:0006706) | 1.64520492 |
| 96 | Progressive cerebellar ataxia (HP:0002073) | 1.64322959 |
| 97 | Abnormality of the renal cortex (HP:0011035) | 1.63874872 |
| 98 | Agammaglobulinemia (HP:0004432) | 1.63342548 |
| 99 | Stomach cancer (HP:0012126) | 1.63272146 |
| 100 | Ketosis (HP:0001946) | 1.62804180 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TLK1 | 3.48824788 |
| 2 | MAP4K1 | 3.35117157 |
| 3 | TAOK3 | 3.21053361 |
| 4 | BCKDK | 3.15911296 |
| 5 | TXK | 2.84824832 |
| 6 | ADRBK2 | 2.74761353 |
| 7 | MAP3K11 | 2.65254342 |
| 8 | ZAK | 2.48064987 |
| 9 | NME2 | 2.20821372 |
| 10 | TESK2 | 2.05403741 |
| 11 | INSRR | 1.88934832 |
| 12 | KDR | 1.88561986 |
| 13 | FRK | 1.86615268 |
| 14 | GRK1 | 1.85483922 |
| 15 | MAP4K2 | 1.84379531 |
| 16 | VRK2 | 1.78859845 |
| 17 | PINK1 | 1.76070282 |
| 18 | IKBKB | 1.71864494 |
| 19 | KIT | 1.50832300 |
| 20 | GRK6 | 1.50112135 |
| 21 | TNK2 | 1.41257317 |
| 22 | DAPK2 | 1.39571024 |
| 23 | CAMKK2 | 1.36336130 |
| 24 | PIM2 | 1.35640364 |
| 25 | TBK1 | 1.33438481 |
| 26 | LIMK1 | 1.32897312 |
| 27 | IKBKE | 1.28969515 |
| 28 | MAPKAPK3 | 1.27793113 |
| 29 | MAPK13 | 1.20533354 |
| 30 | DYRK2 | 1.17345637 |
| 31 | ABL2 | 1.14995247 |
| 32 | SYK | 1.14643382 |
| 33 | BLK | 1.11114707 |
| 34 | WNK4 | 1.09462184 |
| 35 | MAP2K6 | 1.08923189 |
| 36 | MUSK | 1.07742320 |
| 37 | FES | 1.06811379 |
| 38 | GRK7 | 1.04680725 |
| 39 | MAPK15 | 1.02828219 |
| 40 | BMPR1B | 1.01526643 |
| 41 | NUAK1 | 1.00348051 |
| 42 | MAP2K2 | 0.99438933 |
| 43 | SIK2 | 0.99002208 |
| 44 | CDK19 | 0.97394147 |
| 45 | ADRBK1 | 0.95435431 |
| 46 | MAP2K7 | 0.95149157 |
| 47 | VRK1 | 0.88019622 |
| 48 | CAMKK1 | 0.86921179 |
| 49 | RPS6KA5 | 0.86315791 |
| 50 | WNK3 | 0.85995942 |
| 51 | FLT3 | 0.84042059 |
| 52 | STK16 | 0.83822503 |
| 53 | PRKCQ | 0.83333006 |
| 54 | CSNK1G3 | 0.79084873 |
| 55 | LYN | 0.77329797 |
| 56 | RIPK4 | 0.74915603 |
| 57 | ACVR1B | 0.74761610 |
| 58 | BTK | 0.74044673 |
| 59 | GRK5 | 0.73715166 |
| 60 | TESK1 | 0.73436789 |
| 61 | RPS6KA6 | 0.72399391 |
| 62 | CSF1R | 0.71074813 |
| 63 | PRKD2 | 0.69934445 |
| 64 | MATK | 0.69820807 |
| 65 | PRKCG | 0.68483057 |
| 66 | LCK | 0.68060064 |
| 67 | PKN1 | 0.67193173 |
| 68 | ITK | 0.66380559 |
| 69 | CSNK1G2 | 0.65781901 |
| 70 | OXSR1 | 0.64990423 |
| 71 | ZAP70 | 0.64433570 |
| 72 | IRAK4 | 0.59087436 |
| 73 | CAMK1 | 0.56989139 |
| 74 | DAPK1 | 0.56897851 |
| 75 | MAP3K4 | 0.56254602 |
| 76 | CHUK | 0.53584129 |
| 77 | NME1 | 0.53279222 |
| 78 | JAK3 | 0.52172346 |
| 79 | PHKG1 | 0.51886011 |
| 80 | PHKG2 | 0.51886011 |
| 81 | CSNK1A1L | 0.50117873 |
| 82 | CSNK1G1 | 0.49700718 |
| 83 | TIE1 | 0.46049408 |
| 84 | DAPK3 | 0.46038530 |
| 85 | MAPK12 | 0.45504721 |
| 86 | PIM1 | 0.45458878 |
| 87 | PRKACA | 0.42956993 |
| 88 | PRKCA | 0.42651084 |
| 89 | MAP3K13 | 0.40301255 |
| 90 | AURKA | 0.40171678 |
| 91 | EPHA4 | 0.40147168 |
| 92 | MAPK4 | 0.40123674 |
| 93 | ERN1 | 0.40111982 |
| 94 | MAP2K4 | 0.39212445 |
| 95 | RPS6KC1 | 0.39041291 |
| 96 | RPS6KL1 | 0.39041291 |
| 97 | MARK3 | 0.38812206 |
| 98 | OBSCN | 0.38107244 |
| 99 | NTRK2 | 0.37380599 |
| 100 | PRKCD | 0.37209158 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.69619797 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 2.95876701 |
| 3 | Sulfur relay system_Homo sapiens_hsa04122 | 2.66383543 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.64935497 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 2.57171494 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.46898650 |
| 7 | Asthma_Homo sapiens_hsa05310 | 2.42857904 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.35968813 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.19594890 |
| 10 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.17691726 |
| 11 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.10471919 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.09576554 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.00054613 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.99883954 |
| 15 | Phototransduction_Homo sapiens_hsa04744 | 1.97862733 |
| 16 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.93041099 |
| 17 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.92986530 |
| 18 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.89368891 |
| 19 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.82649543 |
| 20 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.78885642 |
| 21 | Huntingtons disease_Homo sapiens_hsa05016 | 1.74944989 |
| 22 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.73538689 |
| 23 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.67041922 |
| 24 | RNA polymerase_Homo sapiens_hsa03020 | 1.65706604 |
| 25 | Proteasome_Homo sapiens_hsa03050 | 1.58298588 |
| 26 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.55569100 |
| 27 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.49138414 |
| 28 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.48954398 |
| 29 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.48879157 |
| 30 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.42493112 |
| 31 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.34386820 |
| 32 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.31186101 |
| 33 | Homologous recombination_Homo sapiens_hsa03440 | 1.27580859 |
| 34 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.21516628 |
| 35 | Nicotine addiction_Homo sapiens_hsa05033 | 1.20751405 |
| 36 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.19920551 |
| 37 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.12307142 |
| 38 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.11076050 |
| 39 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.09322073 |
| 40 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.04240804 |
| 41 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.03467375 |
| 42 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.00863898 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.99573057 |
| 44 | Lysosome_Homo sapiens_hsa04142 | 0.97644003 |
| 45 | Peroxisome_Homo sapiens_hsa04146 | 0.93961212 |
| 46 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.91645822 |
| 47 | Morphine addiction_Homo sapiens_hsa05032 | 0.91290274 |
| 48 | Olfactory transduction_Homo sapiens_hsa04740 | 0.84557700 |
| 49 | Base excision repair_Homo sapiens_hsa03410 | 0.83970777 |
| 50 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.82847723 |
| 51 | Other glycan degradation_Homo sapiens_hsa00511 | 0.79833859 |
| 52 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.78903377 |
| 53 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.76504790 |
| 54 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.76167859 |
| 55 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.75768312 |
| 56 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.75674608 |
| 57 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.75182331 |
| 58 | Leishmaniasis_Homo sapiens_hsa05140 | 0.73117128 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.73053097 |
| 60 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.70927810 |
| 61 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.69307733 |
| 62 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.69171437 |
| 63 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.67005837 |
| 64 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.64500564 |
| 65 | Metabolic pathways_Homo sapiens_hsa01100 | 0.59693762 |
| 66 | Purine metabolism_Homo sapiens_hsa00230 | 0.58941520 |
| 67 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.58236123 |
| 68 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.57204306 |
| 69 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.56450708 |
| 70 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.53563054 |
| 71 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.53318667 |
| 72 | Tuberculosis_Homo sapiens_hsa05152 | 0.51049160 |
| 73 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.50174672 |
| 74 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.49783510 |
| 75 | Circadian entrainment_Homo sapiens_hsa04713 | 0.49657878 |
| 76 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.49291331 |
| 77 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.48964842 |
| 78 | Salivary secretion_Homo sapiens_hsa04970 | 0.47967398 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.46881079 |
| 80 | GABAergic synapse_Homo sapiens_hsa04727 | 0.45455886 |
| 81 | Taste transduction_Homo sapiens_hsa04742 | 0.45104381 |
| 82 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.44837297 |
| 83 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.42079954 |
| 84 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.41471185 |
| 85 | RNA degradation_Homo sapiens_hsa03018 | 0.40879165 |
| 86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.38578925 |
| 87 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.37964843 |
| 88 | Viral myocarditis_Homo sapiens_hsa05416 | 0.36840027 |
| 89 | Protein export_Homo sapiens_hsa03060 | 0.36695826 |
| 90 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.36279364 |
| 91 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.36204158 |
| 92 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34508202 |
| 93 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.33772253 |
| 94 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.33355738 |
| 95 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.32604726 |
| 96 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.32396507 |
| 97 | Insulin secretion_Homo sapiens_hsa04911 | 0.30616319 |
| 98 | Pertussis_Homo sapiens_hsa05133 | 0.28970111 |
| 99 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.28813284 |
| 100 | Mineral absorption_Homo sapiens_hsa04978 | 0.28399618 |

